OppenheimerFunds’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
$17.7M Sell
123,495
-1,873
-1% -$268K 0.02% 566
2018
Q4
$15.5M Buy
125,368
+14,690
+13% +$1.82M 0.02% 568
2018
Q3
$18.6M Sell
110,678
-7,060
-6% -$1.19M 0.02% 602
2018
Q2
$20.3M Sell
117,738
-20,895
-15% -$3.6M 0.02% 576
2018
Q1
$20.9M Sell
138,633
-12,221
-8% -$1.85M 0.03% 555
2017
Q4
$20.3M Sell
150,854
-58,116
-28% -$7.83M 0.02% 575
2017
Q3
$30.6M Buy
208,970
+4,080
+2% +$597K 0.04% 439
2017
Q2
$31.9M Buy
204,890
+54,050
+36% +$8.4M 0.04% 420
2017
Q1
$21.9M Buy
150,840
+52,960
+54% +$7.69M 0.03% 550
2016
Q4
$10.7M Hold
97,880
0.01% 745
2016
Q3
$11.9M Sell
97,880
-14,500
-13% -$1.76M 0.01% 700
2016
Q2
$15.9M Buy
112,380
+49,500
+79% +$6.99M 0.02% 624
2016
Q1
$8.21M Buy
62,880
+890
+1% +$116K 0.01% 752
2015
Q4
$8.71M Sell
61,990
-2,460
-4% -$346K 0.01% 762
2015
Q3
$8.56M Sell
64,450
-13,050
-17% -$1.73M 0.01% 751
2015
Q2
$13.6M Buy
77,500
+18,650
+32% +$3.28M 0.02% 685
2015
Q1
$10.2M Buy
58,850
+2,980
+5% +$515K 0.01% 752
2014
Q4
$9.15M Buy
+55,870
New +$9.15M 0.01% 781
2014
Q2
Sell
-171,916
Closed -$23.8M 928
2014
Q1
$23.8M Sell
171,916
-63,770
-27% -$8.84M 0.03% 531
2013
Q4
$29.8M Buy
235,686
+4,690
+2% +$594K 0.04% 470
2013
Q3
$21.2M Sell
230,996
-22,180
-9% -$2.04M 0.03% 519
2013
Q2
$17.4M Buy
+253,176
New +$17.4M 0.03% 544